0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psychobiotic Supplements Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-21N18503
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Psychobiotic Supplements Market Research Report 2024
BUY CHAPTERS

Global Psychobiotic Supplements Market Research Report 2026

Code: QYRE-Auto-21N18503
Report
2026-01-23
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Psychobiotic Supplements Market

The global Psychobiotic Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Psychobiotic Supplements competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Psychobiotic supplements are those that can positively impact mental health by influencing the interaction between the gut microbiota and the host brain. These supplements typically contain probiotics, prebiotics, or other beneficial microbial ingredients and are intended to improve mood, reduce symptoms of anxiety and depression, and enhance overall mental health.
The North American market for Psychobiotic Supplements is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Psychobiotic Supplements is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Psychobiotic Supplements include Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics, SFI Health, Microbiome Labs, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Psychobiotic Supplements market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Psychobiotic Supplements. The Psychobiotic Supplements market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Psychobiotic Supplements market comprehensively. Regional market sizes by Type, by Sales Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Psychobiotic Supplements manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.
Market Segmentation

Scope of Psychobiotic Supplements Market Report

Report Metric Details
Report Name Psychobiotic Supplements Market
Segment by Type
  • Capsules
  • Tablets
  • Other
  • by Sales Channel
  • Offline Sales
  • Online Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics, SFI Health, Microbiome Labs, G1 NUTRITION
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Psychobiotic Supplements manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Psychobiotic Supplements sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Psychobiotic Supplements Market report?

Ans: The main players in the Psychobiotic Supplements Market are Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics, SFI Health, Microbiome Labs, G1 NUTRITION

What are the Type segmentation covered in the Psychobiotic Supplements Market report?

Ans: The Types covered in the Psychobiotic Supplements Market report are Capsules, Tablets, Other, by Sales Channel, Offline Sales, Online Sales

1 Psychobiotic Supplements Market Overview
1.1 Product Definition
1.2 Psychobiotic Supplements by Type
1.2.1 Global Psychobiotic Supplements Market Value by Type: 2025 vs 2032
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Other
1.3 Psychobiotic Supplements by Sales Channel
1.3.1 Global Psychobiotic Supplements Market Value by Sales Channel: 2025 vs 2032
1.3.2 Offline Sales
1.3.3 Online Sales
1.4 Global Psychobiotic Supplements Market Size Estimates and Forecasts
1.4.1 Global Psychobiotic Supplements Revenue 2021–2032
1.4.2 Global Psychobiotic Supplements Sales 2021–2032
1.4.3 Global Psychobiotic Supplements Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Psychobiotic Supplements Market Competition by Manufacturers
2.1 Global Psychobiotic Supplements Sales Market Share by Manufacturers (2021–2026)
2.2 Global Psychobiotic Supplements Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Psychobiotic Supplements Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Psychobiotic Supplements, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Psychobiotic Supplements, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Psychobiotic Supplements, Product Types and Applications
2.7 Global Key Manufacturers of Psychobiotic Supplements, Date of Entry into the Industry
2.8 Global Psychobiotic Supplements Market Competitive Situation and Trends
2.8.1 Global Psychobiotic Supplements Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Psychobiotic Supplements Players Market Share by Revenue
2.8.3 Global Psychobiotic Supplements Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psychobiotic Supplements Market Scenario by Region
3.1 Global Psychobiotic Supplements Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Psychobiotic Supplements Sales by Region: 2021–2032
3.2.1 Global Psychobiotic Supplements Sales by Region: 2021–2026
3.2.2 Global Psychobiotic Supplements Sales by Region: 2027–2032
3.3 Global Psychobiotic Supplements Revenue by Region: 2021–2032
3.3.1 Global Psychobiotic Supplements Revenue by Region: 2021–2026
3.3.2 Global Psychobiotic Supplements Revenue by Region: 2027–2032
3.4 North America Psychobiotic Supplements Market Facts & Figures by Country
3.4.1 North America Psychobiotic Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Psychobiotic Supplements Sales by Country (2021–2032)
3.4.3 North America Psychobiotic Supplements Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psychobiotic Supplements Market Facts & Figures by Country
3.5.1 Europe Psychobiotic Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Psychobiotic Supplements Sales by Country (2021–2032)
3.5.3 Europe Psychobiotic Supplements Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psychobiotic Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Psychobiotic Supplements Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Psychobiotic Supplements Sales by Region (2021–2032)
3.6.3 Asia Pacific Psychobiotic Supplements Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Psychobiotic Supplements Market Facts & Figures by Country
3.7.1 Latin America Psychobiotic Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Psychobiotic Supplements Sales by Country (2021–2032)
3.7.3 Latin America Psychobiotic Supplements Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Psychobiotic Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Psychobiotic Supplements Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Psychobiotic Supplements Sales by Country (2021–2032)
3.8.3 Middle East and Africa Psychobiotic Supplements Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psychobiotic Supplements Sales by Type (2021–2032)
4.1.1 Global Psychobiotic Supplements Sales by Type (2021–2026)
4.1.2 Global Psychobiotic Supplements Sales by Type (2027–2032)
4.1.3 Global Psychobiotic Supplements Sales Market Share by Type (2021–2032)
4.2 Global Psychobiotic Supplements Revenue by Type (2021–2032)
4.2.1 Global Psychobiotic Supplements Revenue by Type (2021–2026)
4.2.2 Global Psychobiotic Supplements Revenue by Type (2027–2032)
4.2.3 Global Psychobiotic Supplements Revenue Market Share by Type (2021–2032)
4.3 Global Psychobiotic Supplements Price by Type (2021–2032)
5 Segment by Sales Channel
5.1 Global Psychobiotic Supplements Sales by Sales Channel (2021–2032)
5.1.1 Global Psychobiotic Supplements Sales by Sales Channel (2021–2026)
5.1.2 Global Psychobiotic Supplements Sales by Sales Channel (2027–2032)
5.1.3 Global Psychobiotic Supplements Sales Market Share by Sales Channel (2021–2032)
5.2 Global Psychobiotic Supplements Revenue by Sales Channel (2021–2032)
5.2.1 Global Psychobiotic Supplements Revenue by Sales Channel (2021–2026)
5.2.2 Global Psychobiotic Supplements Revenue by Sales Channel (2027–2032)
5.2.3 Global Psychobiotic Supplements Revenue Market Share by Sales Channel (2021–2032)
5.3 Global Psychobiotic Supplements Price by Sales Channel (2021–2032)
6 Key Companies Profiled
6.1 Life Extension
6.1.1 Life Extension Company Information
6.1.2 Life Extension Description and Business Overview
6.1.3 Life Extension Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Life Extension Psychobiotic Supplements Product Portfolio
6.1.5 Life Extension Recent Developments/Updates
6.2 Lifted Naturals
6.2.1 Lifted Naturals Company Information
6.2.2 Lifted Naturals Description and Business Overview
6.2.3 Lifted Naturals Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lifted Naturals Psychobiotic Supplements Product Portfolio
6.2.5 Lifted Naturals Recent Developments/Updates
6.3 NEURAXPHARM
6.3.1 NEURAXPHARM Company Information
6.3.2 NEURAXPHARM Description and Business Overview
6.3.3 NEURAXPHARM Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 NEURAXPHARM Psychobiotic Supplements Product Portfolio
6.3.5 NEURAXPHARM Recent Developments/Updates
6.4 Uplift Food Pty Ltd.
6.4.1 Uplift Food Pty Ltd. Company Information
6.4.2 Uplift Food Pty Ltd. Description and Business Overview
6.4.3 Uplift Food Pty Ltd. Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio
6.4.5 Uplift Food Pty Ltd. Recent Developments/Updates
6.5 Nutrimmun GmbH
6.5.1 Nutrimmun GmbH Company Information
6.5.2 Nutrimmun GmbH Description and Business Overview
6.5.3 Nutrimmun GmbH Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nutrimmun GmbH Psychobiotic Supplements Product Portfolio
6.5.5 Nutrimmun GmbH Recent Developments/Updates
6.6 InnovixLabs
6.6.1 InnovixLabs Company Information
6.6.2 InnovixLabs Description and Business Overview
6.6.3 InnovixLabs Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 InnovixLabs Psychobiotic Supplements Product Portfolio
6.6.5 InnovixLabs Recent Developments/Updates
6.7 Optibac Probiotics
6.7.1 Optibac Probiotics Company Information
6.7.2 Optibac Probiotics Description and Business Overview
6.7.3 Optibac Probiotics Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Optibac Probiotics Psychobiotic Supplements Product Portfolio
6.7.5 Optibac Probiotics Recent Developments/Updates
6.8 Seraphina Therapeutics
6.8.1 Seraphina Therapeutics Company Information
6.8.2 Seraphina Therapeutics Description and Business Overview
6.8.3 Seraphina Therapeutics Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Seraphina Therapeutics Psychobiotic Supplements Product Portfolio
6.8.5 Seraphina Therapeutics Recent Developments/Updates
6.9 SFI Health
6.9.1 SFI Health Company Information
6.9.2 SFI Health Description and Business Overview
6.9.3 SFI Health Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 SFI Health Psychobiotic Supplements Product Portfolio
6.9.5 SFI Health Recent Developments/Updates
6.10 Microbiome Labs
6.10.1 Microbiome Labs Company Information
6.10.2 Microbiome Labs Description and Business Overview
6.10.3 Microbiome Labs Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Microbiome Labs Psychobiotic Supplements Product Portfolio
6.10.5 Microbiome Labs Recent Developments/Updates
6.11 G1 NUTRITION
6.11.1 G1 NUTRITION Company Information
6.11.2 G1 NUTRITION Description and Business Overview
6.11.3 G1 NUTRITION Psychobiotic Supplements Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 G1 NUTRITION Psychobiotic Supplements Product Portfolio
6.11.5 G1 NUTRITION Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psychobiotic Supplements Industry Chain Analysis
7.2 Psychobiotic Supplements Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psychobiotic Supplements Production Mode & Process Analysis
7.4 Psychobiotic Supplements Sales and Marketing
7.4.1 Psychobiotic Supplements Sales Channels
7.4.2 Psychobiotic Supplements Distributors
7.5 Psychobiotic Supplements Customer Analysis
8 Psychobiotic Supplements Market Dynamics
8.1 Psychobiotic Supplements Industry Trends
8.2 Psychobiotic Supplements Market Drivers
8.3 Psychobiotic Supplements Market Challenges
8.4 Psychobiotic Supplements Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Psychobiotic Supplements Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Psychobiotic Supplements Market Value by Sales Channel (US$ Million), 2025 vs 2032
 Table 3. Global Psychobiotic Supplements Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Psychobiotic Supplements Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Psychobiotic Supplements Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Psychobiotic Supplements Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Psychobiotic Supplements Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Psychobiotic Supplements Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Psychobiotic Supplements, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Psychobiotic Supplements, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Psychobiotic Supplements, Product Types and Applications
 Table 12. Global Key Manufacturers of Psychobiotic Supplements, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psychobiotic Supplements Companies by Tier (Tier 1, Tier 2, Tier 3), based on Psychobiotic Supplements Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psychobiotic Supplements Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Psychobiotic Supplements Sales by Region (K Units), 2021–2026
 Table 18. Global Psychobiotic Supplements Sales Market Share by Region (2021–2026)
 Table 19. Global Psychobiotic Supplements Sales by Region (K Units), 2027–2032
 Table 20. Global Psychobiotic Supplements Sales Market Share by Region (2027–2032)
 Table 21. Global Psychobiotic Supplements Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Psychobiotic Supplements Revenue Market Share by Region (2021–2026)
 Table 23. Global Psychobiotic Supplements Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Psychobiotic Supplements Revenue Market Share by Region (2027–2032)
 Table 25. North America Psychobiotic Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Psychobiotic Supplements Sales by Country (K Units), 2021–2026
 Table 27. North America Psychobiotic Supplements Sales by Country (K Units), 2027–2032
 Table 28. North America Psychobiotic Supplements Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Psychobiotic Supplements Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Psychobiotic Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Psychobiotic Supplements Sales by Country (K Units), 2021–2026
 Table 32. Europe Psychobiotic Supplements Sales by Country (K Units), 2027–2032
 Table 33. Europe Psychobiotic Supplements Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Psychobiotic Supplements Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Psychobiotic Supplements Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Psychobiotic Supplements Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Psychobiotic Supplements Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Psychobiotic Supplements Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Psychobiotic Supplements Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Psychobiotic Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Psychobiotic Supplements Sales by Country (K Units), 2021–2026
 Table 42. Latin America Psychobiotic Supplements Sales by Country (K Units), 2027–2032
 Table 43. Latin America Psychobiotic Supplements Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Psychobiotic Supplements Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Psychobiotic Supplements Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Psychobiotic Supplements Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Psychobiotic Supplements Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Psychobiotic Supplements Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Psychobiotic Supplements Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Psychobiotic Supplements Sales (K Units) by Type (2021–2026)
 Table 51. Global Psychobiotic Supplements Sales (K Units) by Type (2027–2032)
 Table 52. Global Psychobiotic Supplements Sales Market Share by Type (2021–2026)
 Table 53. Global Psychobiotic Supplements Sales Market Share by Type (2027–2032)
 Table 54. Global Psychobiotic Supplements Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Psychobiotic Supplements Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Psychobiotic Supplements Revenue Market Share by Type (2021–2026)
 Table 57. Global Psychobiotic Supplements Revenue Market Share by Type (2027–2032)
 Table 58. Global Psychobiotic Supplements Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Psychobiotic Supplements Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Psychobiotic Supplements Sales (K Units) by Sales Channel (2021–2026)
 Table 61. Global Psychobiotic Supplements Sales (K Units) by Sales Channel (2027–2032)
 Table 62. Global Psychobiotic Supplements Sales Market Share by Sales Channel (2021–2026)
 Table 63. Global Psychobiotic Supplements Sales Market Share by Sales Channel (2027–2032)
 Table 64. Global Psychobiotic Supplements Revenue (US$ Million) by Sales Channel (2021–2026)
 Table 65. Global Psychobiotic Supplements Revenue (US$ Million) by Sales Channel (2027–2032)
 Table 66. Global Psychobiotic Supplements Revenue Market Share by Sales Channel (2021–2026)
 Table 67. Global Psychobiotic Supplements Revenue Market Share by Sales Channel (2027–2032)
 Table 68. Global Psychobiotic Supplements Price (US$/Unit) by Sales Channel (2021–2026)
 Table 69. Global Psychobiotic Supplements Price (US$/Unit) by Sales Channel (2027–2032)
 Table 70. Life Extension Company Information
 Table 71. Life Extension Description and Business Overview
 Table 72. Life Extension Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Life Extension Psychobiotic Supplements Product
 Table 74. Life Extension Recent Developments/Updates
 Table 75. Lifted Naturals Company Information
 Table 76. Lifted Naturals Description and Business Overview
 Table 77. Lifted Naturals Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Lifted Naturals Psychobiotic Supplements Product
 Table 79. Lifted Naturals Recent Developments/Updates
 Table 80. NEURAXPHARM Company Information
 Table 81. NEURAXPHARM Description and Business Overview
 Table 82. NEURAXPHARM Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. NEURAXPHARM Psychobiotic Supplements Product
 Table 84. NEURAXPHARM Recent Developments/Updates
 Table 85. Uplift Food Pty Ltd. Company Information
 Table 86. Uplift Food Pty Ltd. Description and Business Overview
 Table 87. Uplift Food Pty Ltd. Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Uplift Food Pty Ltd. Psychobiotic Supplements Product
 Table 89. Uplift Food Pty Ltd. Recent Developments/Updates
 Table 90. Nutrimmun GmbH Company Information
 Table 91. Nutrimmun GmbH Description and Business Overview
 Table 92. Nutrimmun GmbH Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Nutrimmun GmbH Psychobiotic Supplements Product
 Table 94. Nutrimmun GmbH Recent Developments/Updates
 Table 95. InnovixLabs Company Information
 Table 96. InnovixLabs Description and Business Overview
 Table 97. InnovixLabs Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. InnovixLabs Psychobiotic Supplements Product
 Table 99. InnovixLabs Recent Developments/Updates
 Table 100. Optibac Probiotics Company Information
 Table 101. Optibac Probiotics Description and Business Overview
 Table 102. Optibac Probiotics Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Optibac Probiotics Psychobiotic Supplements Product
 Table 104. Optibac Probiotics Recent Developments/Updates
 Table 105. Seraphina Therapeutics Company Information
 Table 106. Seraphina Therapeutics Description and Business Overview
 Table 107. Seraphina Therapeutics Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Seraphina Therapeutics Psychobiotic Supplements Product
 Table 109. Seraphina Therapeutics Recent Developments/Updates
 Table 110. SFI Health Company Information
 Table 111. SFI Health Description and Business Overview
 Table 112. SFI Health Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. SFI Health Psychobiotic Supplements Product
 Table 114. SFI Health Recent Developments/Updates
 Table 115. Microbiome Labs Company Information
 Table 116. Microbiome Labs Description and Business Overview
 Table 117. Microbiome Labs Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Microbiome Labs Psychobiotic Supplements Product
 Table 119. Microbiome Labs Recent Developments/Updates
 Table 120. G1 NUTRITION Company Information
 Table 121. G1 NUTRITION Description and Business Overview
 Table 122. G1 NUTRITION Psychobiotic Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. G1 NUTRITION Psychobiotic Supplements Product
 Table 124. G1 NUTRITION Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Psychobiotic Supplements Distributors List
 Table 128. Psychobiotic Supplements Customers List
 Table 129. Psychobiotic Supplements Market Trends
 Table 130. Psychobiotic Supplements Market Drivers
 Table 131. Psychobiotic Supplements Market Challenges
 Table 132. Psychobiotic Supplements Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psychobiotic Supplements
 Figure 2. Global Psychobiotic Supplements Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Psychobiotic Supplements Market Share by Type: 2025 & 2032
 Figure 4. Capsules Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Psychobiotic Supplements Market Value by Sales Channel (US$ Million), 2021–2032
 Figure 8. Global Psychobiotic Supplements Market Share by Sales Channel: 2025 & 2032
 Figure 9. Offline Sales
 Figure 10. Online Sales
 Figure 11. Global Psychobiotic Supplements Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Psychobiotic Supplements Market Size (US$ Million), 2021–2032
 Figure 13. Global Psychobiotic Supplements Sales (K Units), 2021–2032
 Figure 14. Global Psychobiotic Supplements Average Price (US$/Unit), 2021–2032
 Figure 15. Psychobiotic Supplements Report Years Considered
 Figure 16. Psychobiotic Supplements Sales Share by Manufacturers in 2025
 Figure 17. Global Psychobiotic Supplements Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Psychobiotic Supplements Players: Market Share by Revenue in Psychobiotic Supplements in 2025
 Figure 19. Psychobiotic Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Psychobiotic Supplements Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Psychobiotic Supplements Sales Market Share by Country (2021–2032)
 Figure 22. North America Psychobiotic Supplements Revenue Market Share by Country (2021–2032)
 Figure 23. United States Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Psychobiotic Supplements Sales Market Share by Country (2021–2032)
 Figure 26. Europe Psychobiotic Supplements Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Psychobiotic Supplements Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Psychobiotic Supplements Revenue Market Share by Region (2021–2032)
 Figure 34. China Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Psychobiotic Supplements Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Psychobiotic Supplements Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Psychobiotic Supplements Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Psychobiotic Supplements Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Psychobiotic Supplements Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Psychobiotic Supplements by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Psychobiotic Supplements by Type (2021–2032)
 Figure 54. Global Psychobiotic Supplements Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Psychobiotic Supplements by Sales Channel (2021–2032)
 Figure 56. Global Revenue Market Share of Psychobiotic Supplements by Sales Channel (2021–2032)
 Figure 57. Global Psychobiotic Supplements Price (US$/Unit) by Sales Channel (2021–2032)
 Figure 58. Psychobiotic Supplements Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI